MeSH Browser

MeSH Heading: Acitretin
Tree Number(s): D02.455.326.271.665.202.495.050; D02.455.849.131.495.050; D23.767.261.700.050
Unique ID: D017255
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D017255
Scope Note: An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Entry Term(s): 13-cis-Acitretin; Acitretin, (Z,E,E,E)-Isomer; Etretin; Isoacitretin; Isoetretin; Neotigason; Ro 10-1670; Ro 13-7652; Ro-10-1670; Ro-13-7652; Soriatane
Pharm Action: Keratolytic Agents
Registry Number: LCH760E9T7
Related Numbers: 54757-46-9; 55079-83-9; 69427-46-9
CAS Type 1 Name: 2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-
Previous Indexing: Tretinoin/analogs & derivatives (1977-1992)
Public MeSH Note: 93; ACITRETIN was indexed under TRETINOIN/analogs & derivatives 1977-92
Online Note: use ACITRETIN (NM) to search ACITRETIN 1980-92
History Note: 93; was ACITRETIN (NM) 1977-91
Date Established: 1993/01/01
Date of Entry: 1992/05/07
Revision Date: 2017/02/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Acitretin MeSH Descriptor Data 2024